A cardiac magnetic resonance imaging study of electrocardiographic Q waves in type 2 diabetes: The Fremantle Diabetes Study

Diabetes Research and Clinical Practice

Volumn 82, Issue 1, 2008, Pages 87-92

  Kondola, Sanjana ^a   Davis, Wendy A ^a   Dembo, Lawrence G ^b   Davis, Timothy M E ^a  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b ST JOHN OF GOD HOSPITAL   (Australia)

Author keywords

Coronary heart disease; Electrocardiographic Q waves; Magnetic resonance imaging; Silent myocardial infarction; Type 2 diabetes mellitus

Indexed keywords

CHOLESTEROL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DISEASE COURSE; DISEASE DURATION; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW UP; HUMAN; IMAGE ANALYSIS; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; Q WAVE;

AGED; CORONARY DISEASE; DIABETES MELLITUS, TYPE 2; ELECTROCARDIOGRAPHY; FEMALE; HUMANS; LONGITUDINAL STUDIES; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; WESTERN AUSTRALIA;

EID: 52949131485     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabres.2008.06.016     Document Type: Article

References (36)

1. Bateman T.M., Czer L.S., Gray R.J., Maddahi J., Raymond M.J., Geft I.L., et al. Transient pathologic Q waves during acute ischemic events: an electrocardiographic correlate of stunned but viable myocardium. Am. Heart J. 106 (1983) 1421-1426
2. Engblom H., Carlsson M.B., Hedstrom E., Heiberg E., Ugander M., Wagner G.S., et al. The endocardial extent of reperfused first-time myocardial infarction is more predictive of pathologic Q waves than is infarct transmurality: a magnetic resonance imaging study. Clin. Physiol. Funct. Imaging 27 (2007) 101-108
3. Marcus E.B., Yano K., and MacLean C.J. Regression of Q waves following acute myocardial infarction. Am. J. Epidemiol. 129 (1989) 105-111
4. Davis T.M., Fortun P., Mulder J., Davis W.A., and Bruce D.G. Silent myocardial infarction and its prognosis in a community-based cohort of Type 2 diabetic patients: the Fremantle Diabetes Study. Diabetologia 47 (2004) 395-399
5. Ingkanisorn W.P., Rhoads K.L., Aletras A.H., Kellman P., and Arai A.E. Gadolinium delayed enhancement cardiovascular magnetic resonance correlates with clinical measures of myocardial infarction. J. Am. Coll. Cardiol. 43 (2004) 2253-2259
6. Kim R.J., Fieno D.S., Parrish T.B., Harris K., Chen E.L., Simonetti O., et al. Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function. Circulation 100 (1999) 1992-2002
7. Ricciardi M.J., Wu E., Davidson C.J., Choi K.M., Klocke F.J., Bonow R.O., et al. Visualization of discrete microinfarction after percutaneous coronary intervention associated with mild creatine kinase-MB elevation. Circulation 103 (2001) 2780-2783
8. Al-Mohammad A., Norton M.Y., Mahy I.R., Patel J.C., Welch A.E., Mikecz P., et al. Can the surface electrocardiogram be used to predict myocardial viability?. Heart 82 (1999) 663-667
9. Asch F.M., Shah S., Rattin C., Swaminathan S., Fuisz A., Lindsay J., et al. Lack of sensitivity of the electrocardiogram for detection of old myocardial infarction: a cardiac magnetic resonance imaging study. Am. Heart J. 152 (2006) 742-748
10. Sandler L.L., Pinnow E.E., and Lindsay J. The accuracy of electrocardiographic Q waves for the detection of prior myocardial infarction as assessed by a novel standard of reference. Clin. Cardiol. 27 (2004) 97-100
11. Rovai D., Di Bella G., Rossi G., Lombardi M., Aquaro G.D., L'Abbate A., et al. Q-wave prediction of myocardial infarct location, size and transmural extent at magnetic resonance imaging. Coron. Artery Dis. 18 (2007) 381-389
12. Moon J.C., De Arenaza D.P., Elkington A.G., Taneja A.K., John A.S., Wang D., et al. The pathologic basis of Q-wave and non-Q-wave myocardial infarction: a cardiovascular magnetic resonance study. J. Am. Coll. Cardiol. 44 (2004) 554-560
13. Davis T.M., Zimmet P., Davis W.A., Bruce D.G., Fida S., Mackay I.R., et al. Autoantibodies to glutamic acid decarboxylase in diabetic patients from a multi-ethnic Australian community: the Fremantle Diabetes Study. Diabet. Med. 17 (2000) 667-674
14. Holman C.D., Bass A.J., Rouse I.L., and Hobbs M.S. Population-based linkage of health records in Western Australia: development of a health services research linked database. Aust. N. Z. J. Public Health 23 (1999) 453-459
15. Elgrishi I., Ducimetiere P., and Richard J.L. Reproducibility of analysis of the electrocardiogram in epidemiology using the Minnesota code. Br. J. Prevent. Soc. Med. 24 (1970) 197-200
16. Ammar K.A., Kors J.A., Yawn B.P., and Rodeheffer R.J. Defining unrecognized myocardial infarction: a call for standardized electrocardiographic diagnostic criteria. Am. Heart J. 148 (2004) 277-284
17. Wesbey G.E., Higgins C.B., McNamara M.T., Engelstad B.L., Lipton M.J., Sievers R., et al. Effect of gadolinium-DTPA on the magnetic relaxation times of normal and infarcted myocardium. Radiology 153 (1984) 165-169
18. Bellenger N.G., Burgess M.I., Ray S.G., Lahiri A., Coats A.J., Cleland J.G., et al. Comparison of left ventricular ejection fraction and volumes in heart failure by echocardiography, radionuclide ventriculography and cardiovascular magnetic resonance; are they interchangeable?. Eur. Heart J. 21 (2000) 1387-1396
19. Baer F.M., Theissen P., Voth E., Schneider C.A., Schicha H., Sechtem U., et al. Morphologic correlate of pathologic Q waves as assessed by gradient-echo magnetic resonance imaging. Am. J. Cardiol. 74 (1994) 430-434
20. Klein C., Nekolla S.G., Bengel F.M., Momose M., Sammer A., Haas F., et al. Assessment of myocardial viability with contrast-enhanced magnetic resonance imaging: comparison with positron emission tomography. Circulation 105 (2002) 162-167
21. Wagner A., Mahrholdt H., Holly T.A., Elliott M.D., Regenfus M., Parker M., et al. Contrast-enhanced MRI and routine single photon emission computed tomography (SPECT) perfusion imaging for detection of subendocardial myocardial infarcts: an imaging study. Lancet 361 (2003) 374-379
22. Aguilar D. The clinically unrecognized Q-wave myocardial infarction: what does it mean and what should we do?. Am. Heart J. 151 (2006) 768-770
23. Sztajzel J., and Urban P. Early and late Q wave regression in the setting of acute myocardial infarction. Heart 83 (2000) 708-710
24. Wackers F.J., Chyun D.A., Young L.H., Heller G.V., Iskandrian A.E., Davey J.A., et al. Resolution of asymptomatic myocardial ischemia in patients with type 2 diabetes in the Detection of Ischemia in Asymptomatic Diabetics (DIAD) study. Diabetes Care 30 (2007) 2892-2898
25. American Diabetes Association. Standards of medical care in diabetes. Diabetes Care 31 Suppl.1 (2008) S12-54
26. Choi E.K., Koo B.K., Kim H.S., Cho Y.M., Kang H.J., Cho Y.S., et al. Prognostic significance of asymptomatic coronary artery disease in patients with diabetes and need for early revascularization therapy. Diabet. Med. 24 (2007) 1003-1011
27. Kannel W.B., and Abbott R.D. Incidence and prognosis of unrecognized myocardial infarction. An update on the Framingham Study. N. Engl. J. Med. 311 (1984) 1144-1147
28. Kannel W.B., Dannenberg A.L., and Abbott R.D. Unrecognized myocardial infarction and hypertension: the Framingham Study. Am. Heart J. 109 (1985) 581-585
29. Medalie J.H., and Goldbourt U. Unrecognized myocardial infarction: five-year incidence, mortality, and risk factors. Ann. Intern. Med. 84 (1976) 526-531
30. Nadelmann J., Frishman W.H., Ooi W.L., Tepper D., Greenberg S., Guzik H., et al. Prevalence, incidence and prognosis of recognized and unrecognized myocardial infarction in persons aged 75 years or older: the Bronx Aging Study. Am. J. Cardiol. 66 (1990) 533-537
31. Rosenman R.H., Friedman M., Jenkins C.D., Struas R., Wurm M., Kositchek R., et al. Clinically unrecognized myocardial infarction in the Western Collaborative Group Study. Am. J. Cardiol. 19 (1967) 776-782
32. Sigurdsson E., Thorgeirsson G., Sigvaldason H., and Sigfusson N. Unreconized myocardial infarction: epidemiology, clinical charcteristics, and the prognostic role of angina pectoris. Ann. Intern. Med. 122 (1995) 96-102
33. Kwong R.Y., Chan A.K., Brown K.A., Chan C.W., Reynolds H.G., Tsang S., et al. Impact of unrecognized myocardial scar detected by cardiac magnetic resonance imaging on event-free survival in patients presenting with signs or symptoms of coronary artery disease. Circulation 113 (2006) 2733-2743
34. American Diabetes Association, Consensus development conference on the diagnosis of coronary heart disease in people with diabetes: February 10-11, 1998, Miami, Florida, Diabetes Care 21 (1998) 1551-1559.
35. Hashimoto T., Kambara H., Fudo T., Hayashi M., Tamaki S., Tokunaga S., et al. Non-Q wave versus Q wave myocardial infarction: regional myocardial metabolism and blood flow assessed by positron emission tomography. J. Am. Coll. Cardiol. 12 (1988) 88-93
36. Bountioukos M., Schinkel A.F., Bax J.J., Rizzello V., Rambaldi R., Vourvouri E.C., et al. Quantification of regional left ventricular function in Q wave and non-Q wave dysfunctional regions by tissue Doppler imaging in patients with ischaemic cardiomyopathy. Heart 89 (2003) 1322-1326